21 Mar 2026Open access
A multicenter retrospective study of neoadjuvant chemotherapy and breast conservation rate in locally advanced breast cancerPublisher siteDiscover Oncology, Breast Cancer Treatment Studies
UniversitiesLoay Kassem
Active, last published 2026
In breast cancer treatment studies
Loay
Kassem
Scholar“Research focused on Breast Cancer Treatment Studies and adjacent fields.”
Cairo University
Claim Your Profile18
H-index
911
Citations
Loay has not officially claimed their profile. If you are Loay, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
oay Kassem is a researcher working on Breast Cancer Treatment Studies. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Loay's work has been cited 911 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Breast Cancer Treatment Studies×24Advanced Breast Cancer Therapies×20Global Cancer Incidence and Screening×14HER2/EGFR in Cancer Research×12Genomics, phytochemicals, and oxidative stress×10
04 · Where I am
Affiliations
Affiliation on published researchCairo UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works20 Oct 2025Open access
The CAIRO Journal Club: A Decade of ImpactPublisher siteJournal of Cancer Education, Advances in Oncology and Radiotherapy
1 Sept 2025
2315P Governmental pharma-industry partnership transforms Egypt’s breast cancer patient journey: Data from the National Breast Cancer Program (2019–2024)Publisher siteAnnals of Oncology, Economic and Financial Impacts of Cancer
1 Aug 20253cites
Impact of <i>BRCA</i> Mutation on Treatment Outcomes of Endocrine Therapy ± CDK4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor-2–Negative Breast Cancer: A Systematic Review and Meta-AnalysisPublisher siteJCO Precision Oncology, Advanced Breast Cancer Therapies
12 Dec 2024Open access1cites
The cost-effectiveness of treatment for high-risk, early-stage, triple-negative breast cancer in Egypt: an analysis of neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant single-agent pembrolizumabPublisher siteJournal of Medical Economics, Cancer Immunotherapy and Biomarkers
1 Sept 2024Open access
1558P Independent validation of the Breast Cancer Risk Assessment Tool (Gail model) for predicting breast cancer risk in Egyptian populationPublisher siteAnnals of Oncology, Global Cancer Incidence and Screening
10 Jul 2024Open access4cites
Tailoring neoadjuvant systemic therapy in breast cancer: “The advent of a personalized approach”—The Breast‐Gynecological and Immuno‐Oncology International Cancer Conference (BGICC) consensus and recommendationsPublisher siteCancer, Breast Cancer Treatment Studies
1 Jul 2024
The prognostic value of P53 and CA15.3 tumor markers in breast cancer patientPublisher siteJournal of Basic and Environmental Sciences, Cancer-related Molecular Pathways
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Loay?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you